Trospium Chloride Capsule, Extended Release
Product Images NDC 0591-3636
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 0591-3636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Mean (+sd) Concentration-time Profile For A Single 60 mg Oral Dose Of Trospium Chloride Extended-release Capsules In Healthy Volunteers (Image 2)
Figure 2: Mean Change From Baseline In Urinary Frequency/24 Hours By Visit: Study 1 (Image 3)
Figure 3: Mean Change From Baseline In Incontinence Episodes/week By Visit: Study 1 (Image 4)
Figure 4: Mean Change From Baseline In Urinary Frequency/24 Hours By Visit: Study 2 (Image 5)
Figure 5: Mean Change From Baseline In Incontinence Episodes/week By Visit: Study 2 (Image 6)
Label 60mg-30s (Image 7)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.